Intoxicating hemp products: regulatory status

What counts as an intoxicating hemp product?

The term covers consumer products made from federally lawful hemp that deliver an intoxicating dose of THC or a similar compound. Four groups matter commercially:

Product group	How it is made	Why it passed the 2018 test
Delta-8 THC, delta-10 THC, HHC	Chemically converted from hemp CBD	Delta-9 THC at or under 0.3% by dry weight
THC-O, THCP and similar	Synthesised or semi-synthesised	Same argument; disputed by DEA
THCA flower and concentrates	Cannabis harvested and tested with low delta-9 but high THCA, which converts to THC when heated	THCA was not counted in the delta-9 test
Hemp delta-9 edibles and drinks	Hemp-extracted delta-9 THC in a heavy product	A 12-ounce drink can hold several milligrams and stay under 0.3% by weight

The legal definitions behind these groups are in hemp vs marijuana: legal distinction for buyers.

Federal status until late 2026

Under the 2018 definition, federal appeals courts sided with the industry. In AK Futures v. Boyd Street Distro (19 May 2022), a trademark case, the Ninth Circuit found that delta-8 products with no more than 0.3% delta-9 THC fit the plain text of the hemp definition. In Anderson v. Diamondback Investment Group (4 September 2024), an employment case, the Fourth Circuit declined to follow DEA’s view that THC-O is a controlled substance because it is made synthetically.

Neither case was a ruling on product safety. The FDA has said delta-8 products have not been evaluated or approved and has flagged variable potency and contaminants from the conversion process. The FDA’s stated position is that THC and CBD cannot lawfully be added to food or sold as dietary supplements, so these products were never clearly lawful under food and drug law even when they were lawful hemp.

What changes on 12 November and 11 December 2026?

P.L. 119-37 amended 7 U.S.C. 1639o to close each of the four routes above:

• Total THC, including THCA, replaces delta-9 THC in the 0.3% test. That removes high-THCA flower.
• Cannabinoids the plant cannot produce are excluded. That removes the fully synthetic group.
• Cannabinoids the plant can produce but that were made outside the plant are excluded. That removes converted delta-8 and similar compounds.
• Finished products are capped at 0.4 milligrams of total THC, and similar-acting cannabinoids, per container. That removes nearly all hemp edibles and drinks sold for effect.

The original effective date for all of it was 12 November 2026. H.R. 6500, a stopgap funding law signed on 2 September 2026 after a 90 to 6 Senate vote and a 370 to 48 House vote, moved most provisions to 11 December 2026. As read by hemp counsel, the exclusion of cannabinoids the plant cannot naturally produce was not delayed and still applies from 12 November.

Status of related items as of 3 September 2026, per the same summary:

• The FDA had not published the required lists of naturally occurring and THC-class cannabinoids or clarified the term “container”.
• Pending bills included a delay to 12 November 2028 (H.R. 7024 and S. 3686), full repeal (H.R. 6209), a federal regulatory framework (H.R. 9830), and alcohol-style regulation of hemp beverages (H.R. 10079). None had a scheduled vote.
• The White House was reported to have said the 30-day extension was the last it would support.

Once a product falls outside the hemp definition it is marijuana under the Controlled Substances Act. Adult-use marijuana remains Schedule I; see rescheduling status and what it changes.

How are states regulating intoxicating hemp?

States have not waited for the federal date. Three models have emerged.

Model	Example	Rule	Status
Dispensary-only	Ohio	SB 56 requires intoxicating hemp products to be sold through licensed marijuana dispensaries; the governor vetoed a temporary carve-out for THC beverages	In effect 20 March 2026. Trial courts have issued temporary orders for individual businesses, and litigation continues
Fold into the cannabis system	California	AB 8 bans inhalable hemp products and synthetic cannabinoids, allows only THC-free hemp in food and drink from 1 January 2026, and brings hemp cannabinoids into the licensed supply chain by 2028	In effect
Separate licensed hemp channel	Minnesota	Office of Cannabis Management issues lower-potency hemp edible licences for retailers, manufacturers, and wholesalers; products limited to 5 milligrams THC per serving and 50 milligrams per package	Licensing open
Agency tightening	Texas	Sales limited to age 21 and over; a Department of State Health Services rule effective 31 March 2026 counts THCA toward the 0.3% limit, which removes most smokable products	Rule challenged in court; enforcement status was unsettled as of mid-2026

Two practical points follow. First, a state licence for hemp THC products does not change the federal result after 11 December 2026; it only governs state enforcement. Second, the dispensary-only model transfers the category to existing marijuana licence holders, which supports licence values in those states.

What does this mean for business value?

Hemp THC brands, manufacturers, and retailers. Revenue from products above the new limits should be treated as ending on the effective date unless the law changes. Buyers will pay for compliant products, brand equity, and distribution, and will push the rest into contingent consideration. Inventory is a specific problem: stock that cannot lawfully be sold after the date has no value, so inventory counts at closing need a product-by-product legal screen. The seller’s side is covered in selling a hemp or CBD business.

Licensed marijuana businesses. Removal of an untaxed competitor helps, most clearly in states where hemp THC was widely sold in general retail. It is reasonable to note this in a sale process. It is not reasonable to project a specific sales increase without local evidence. For how buyers treat unproven upside, see how much is my cannabis business worth.

Lenders, landlords, and processors. Expect them to ask for certificates of analysis and a written product-compliance position. Businesses that cannot produce one may lose services before the effective date, which is a distress risk in itself.

Timing a sale. A deal signed before the date and closed after it needs a clause saying what happens if Congress delays again, or does not. A price adjustment keyed to the law in force at closing is one common approach. The hemp and CBD businesses hub covers the wider sale considerations.

This summary is educational and current to mid-September 2026. Federal dates have moved once and state rules are in active litigation, so check the current position before relying on any of it.